Philogen SpA (MIL:PHIL) Other Long-Term Liabilities: €1.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:PHIL Philogen SpA MIL:PHIL
49 GF Score
Price €23.95
GF Value €232.55
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA Other Long-Term Liabilities?

Philogen SpA MIL:PHIL -0.42% 49 Other Long-Term Liabilities is €1.1 Mil as of Dec. 2025. GuruFocus rates MIL:PHIL with a GF Score™ of 49/100 and a GF Value™ of €232.55 (Possible Value Trap). The stock has 3 warning signs investors should review.

Philogen SpA's other long-term liabilities for the quarter that ended in Dec. 2025 was €1.1 Mil.

Philogen SpA's quarterly other long-term liabilities declined from Dec. 2024 (€1.4 Mil) to Jun. 2025 (€1.1 Mil) but then increased from Jun. 2025 (€1.1 Mil) to Dec. 2025 (€1.1 Mil).

Philogen SpA's annual other long-term liabilities declined from Dec. 2023 (€3.7 Mil) to Dec. 2024 (€1.4 Mil) and declined from Dec. 2024 (€1.4 Mil) to Dec. 2025 (€1.1 Mil).

Philogen SpA Other Long-Term Liabilities Related Terms

Philogen SpA Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Philogen SpA's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen SpA Other Long-Term Liabilities Chart

Philogen SpA Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 3.93 5.14 3.67 1.39 1.12

Philogen SpA Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.67 1.44 1.39 1.12 1.12
MIL:PHIL
49GF Score
Philogen SpA MIL:PHIL
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Philogen SpA Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €1.1 Mil mean?
Philogen SpA (MIL:PHIL) has a Other Long-Term Liabilities of €1.1 Mil as of Dec. 2025. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Philogen SpA and its competitors.
Is Philogen SpA's Other Long-Term Liabilities too high?
Philogen SpA's current Other Long-Term Liabilities is €1.1 Mil. Overall, Philogen SpA has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Philogen SpA's Other Long-Term Liabilities compare to VRTX and REGN?
Philogen SpA's Other Long-Term Liabilities of €1.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Philogen SpA and its competitors. Philogen SpA's current Other Long-Term Liabilities is €1.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Philogen SpA stock overvalued right now?
Based on GuruFocus' analysis, Philogen SpA (MIL:PHIL) is currently considered Possible Value Trap. The stock's GF Value™ is €232.55, compared to a current price of €23.95 — trading 89.7% below its estimated fair value. The current Other Long-Term Liabilities is €1.1 Mil. Philogen SpA's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Philogen SpA (MIL:PHIL), the current Other Long-Term Liabilities is €1.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Philogen SpA (MIL:PHIL) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €23.95 is trading 89.7% below its estimated GF Value™ of €232.55. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for MIL:PHIL:

  • Other Long-Term Liabilities: €1.1 Mil
  • GF Value™: €232.55 vs. price of €23.95 (89.7% below fair value)
  • GF Score™: 49/100 with 3 warning signs

No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Philogen SpA Business Description

Other Exchanges 78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
49GF Score

Get the complete analysis for MIL:PHIL

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.95
Price
€232.55
GF Value